SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-004913
Filing Date
2019-07-26
Accepted
2019-07-26 17:00:25
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_072619p.htm 10-Q 456586
2 EXHIBIT 10.1 exh_101.htm EX-10.1 129397
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9932
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9923
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3966
12 GRAPHIC morgan.jpg GRAPHIC 2670
  Complete submission text file 0001171843-19-004913.txt   3595913

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE anik-20190630.xml EX-101.INS 648077
7 XBRL SCHEMA FILE anik-20190630.xsd EX-101.SCH 49307
8 XBRL CALCULATION FILE anik-20190630_cal.xml EX-101.CAL 43149
9 XBRL DEFINITION FILE anik-20190630_def.xml EX-101.DEF 305288
10 XBRL LABEL FILE anik-20190630_lab.xml EX-101.LAB 266557
11 XBRL PRESENTATION FILE anik-20190630_pre.xml EX-101.PRE 332549
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 19978592
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services